Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities

Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities

ABSTRACTBecause of its high infectivity in humans and the lack of effective vaccines, Nipah virus is classified as a category C agent and handling has to be performed under biosafety level 4 conditions in non-endemic countries, which has hindered the development of vaccines. Based on a highly effici...

Full description

Bibliographic Details
Main Authors: Jianhui Nie, Lin Liu, Qing Wang, Ruifeng Chen, Tingting Ning, Qiang Liu, Weijin Huang, Youchun Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Emerging Microbes and Infections
Subjects:
Nipah
neutralization
pseudo virus
animal model
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2019.1571871

Internet

https://www.tandfonline.com/doi/10.1080/22221751.2019.1571871

Similar Items